Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04109820 · ClinicalTrials.gov registry record · NA

Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia

A NA study of Sickle Cell Disease, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
5
Study locations

NCT04109820 is a NA study of Sickle Cell Disease that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 15 participants, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (95% lower). The trial reports 5 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04109820, a NA study of Sickle Cell Disease, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
5
Study locations

Study Summary

MitoQ is commercially available as a dietary supplement and it has been tested as a potential drug in other diseases, but it has never been tested in patients with sickle cell disease. The goal of this research is to study if MitoQ, a molecule that works as an antioxidant by removing potentially damaging agents in a living organism, improves platelet function in patients with sickle cell disease (SCD).

Conditions Studied

Sickle Cell Disease

Interventions

  • DIETARY_SUPPLEMENT MitoQ

Study Locations (5)

Pennsylvania

  • Magee Women's Hospital - Pittsburgh
  • UPMC Montefiore - Pittsburgh
  • UPMC Presbyterian - Pittsburgh
  • Children's Hospital of Pittsburgh - Pittsburgh
  • Hillman Cancer Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2020-03-01
Est. Completion 2027-06-30
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04109820

The ClinicalTrials.gov registry entry for NCT04109820 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (95% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which MitoQ is the first listed.

NCT04109820 reports 5 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04109820 about?

NCT04109820 is a clinical study titled "Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia". MitoQ is commercially available as a dietary supplement and it has been tested as a potential drug in other diseases, but it has never been tested in patients with sickle cell disease. The goal of this research is to study if MitoQ, a molecule that works as an antioxidant by removing potentially da...

What is the current status of trial NCT04109820?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2020-03-01. Estimated completion is 2027-06-30.

What conditions does trial NCT04109820 study?

This clinical trial studies the following conditions: Sickle Cell Disease.

What interventions are being tested in trial NCT04109820?

The interventions under investigation include: MitoQ (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04109820?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04109820 being conducted?

This trial has 5 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sickle Cell Disease

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.